Qing F. Ni
Beijing, 100053, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 72 publications
From "bridging specialties" to "owning the patient": rethinking accountability in Cardiovascular-Kidney-Metabolic syndrome care.
Journal: European heart journal. Cardiovascular pharmacotherapy
Published: July 16, 2026
Epigenetic transcriptional regulation of skeletal aging: The emerging role of m6A methylation.
Journal: Journal of orthopaedic translation
Published: November 19, 2025
Hirsutine attenuates renal injury in diabetic kidney disease by regulating Th17 cell differentiation via the TGFβ/SMAD Pathway.
Journal: European journal of pharmacology
Published: October 28, 2025
Morus alba L. (Sangzhi) alkaloids alleviate diabetic nephropathy by suppressing endoplasmic reticulum stress and modulating AMPK-associated phosphatidylethanolamine content.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: October 14, 2025
Nuclear receptor-driven immunometabolic crosstalk: immune-centric pharmacology targeting the inflamed nexus.
Journal: Frontiers in cell and developmental biology
Published: September 16, 2025
Endocrine Regulation of Osteoporosis: Insights from the Brain-Bone Axis Theory.
Journal: Journal of bone metabolism
Published: July 29, 2025
Mechanism of Qingrun Decoction in alleviating hepatic insulin resistance in type 2 diabetic rats based on amino acid metabolism reprogramming pathways
Journal: Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica
Published: July 21, 2025
The molecular mechanisms of disulfidptosis and its role in Diabetes mellitus and its complications.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: June 02, 2025
Neutrophil percentage to albumin ratio and advanced cardiovascular-kidney-metabolic syndrome in diabetes: a machine learning approach.
Journal: European journal of medical research
Published: April 20, 2025
Drug classes associated with the development of fulminant type 1 diabetes: a retrospective analysis using the FDA adverse event reporting system database.
Journal: Expert opinion on drug safety
Published: January 11, 2025
Last Updated: 09/26/2026